-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer - 4/19/2023
1:00:42
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer - 4/13/2023
1:03:24
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in AML and MDS - 4/4/2023
1:02:17
-
Oncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU Activity - 3/29/2023
1:03:11
-
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Endometrial Cancer - 3/27/2023
1:30:52
-
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Ovarian Cancer - 3/26/2023
1:31:48
-
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal and Hepatobiliary Cancers — A 2023 Post-ASCO GI Webcast - 3/8/2023
1:00:33
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Kidney and Bladder Cancer - 3/2/2023
1:03:15
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer - 3/1/2023
1:01:43
-
Oncology Today with Dr Neil Love — Role of PARP Inhibition in Ovarian Cancer and Recent Data with Tumor Treating Fields: A Special Dual-Focused Webinar - 2/23/2023
1:03:31
-
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Prostate Cancer - 2/16/2023
2:03:05
- Next Page
